Background: Vaccines are administered differentially according to age and sex, and disease patterns also vary among people of different age and sex groups. Estimates of disproportionality should be calculated based on comparisons of groups that have a similar likelihood of receiving similar vaccines and experiencing similar adverse events, to prevent false disproportionality from occurring. Stratified empirical Bayesian (EB) methods have been compared with crude, but not stratified, proportional reporting ratios (PRRs) in their performance on adverse event data.

Objectives: (i) to implement stratification of PRR; (ii) to quantify and compare vaccine-event pairs that are highlighted by PRR and EB05 (the lower bound of the 90% CI of the EB geometric mean), for both crude and stratified; and (iii) to evaluate the effects of stratification by age and sex, in identifying adverse events that are accepted to be caused by vaccines.

Methods: We applied EB and PRR data mining methods to data from the US Vaccine Adverse Event Reporting System (VAERS). We stratified PRR and EB05 by age and sex. To study the effects of stratification, we compared the crude PRR and stratified PRR. We also assessed the crude EB05 and stratified EB05, and then compared the effects of stratification on EB05 and PRR.

Results: Stratification not only changed the number of vaccine-event pairs that were highlighted, but also changed which pairs were highlighted. There were 283 vaccine-event pairs that were highlighted by the crude EB05, but not the stratified; 12 that were highlighted by the stratified EB05, but not the crude; and 162 that were highlighted by both. Similarly, there were 701 vaccine-event pairs that were highlighted by the crude PRR, but not the stratified; 139 that were highlighted by the stratified PRR, but not the crude; and 895 that were highlighted by both. There were 1466 vaccine-event pairs in which the effect of stratification was different for EB05 and PRR.

Conclusion: To our knowledge, this is the first published analysis using stratified PRRs. In this analysis of passive surveillance data, stratification revealed and reduced confounding in EB and PRR, and also unmasked some vaccine-event pairs that the crude values did not highlight. Stratification should be applied if confounding is suspected. By decreasing the total number of highlighted vaccine-event pairs, stratification is likely to increase efficiency and therefore might reduce workload.

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002018-200831080-00003DOI Listing

Publication Analysis

Top Keywords

vaccine-event pairs
28
pairs highlighted
20
effects stratification
16
age sex
16
adverse event
12
stratified prr
12
stratified
11
highlighted
10
crude
9
stratification
9

Similar Publications

Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.

Br J Clin Pharmacol

March 2019

Unit of Pharmacology, Department of Medical and Surgical Sciences, University of Bologna, via Irnerio 48, 40126, Bologna, Italy.

Aims: Human papilloma virus (HPV) is the cause of different types of carcinoma. Despite the remarkable effectiveness of the HPV vaccines, there have been many complaints about their risk-benefit profile due to adverse events following immunization (AEFI). The purpose of this study is to analyse the safety profile of the HPV vaccine basing on real-life data derived from reports of suspected AEFIs collected in the US Vaccine Adverse Events Reporting System (VAERS) and assess if the searches on Google overlap with spontaneous reporting.

View Article and Find Full Text PDF

Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.

Drug Saf

December 2016

Département de Pharmacologie médicale, Centre Régional de Pharmacovigilance, CHU Bordeaux, Hôpital Pellegrin-Bât. 1A Zone Nord, 33076, Bordeaux Cedex, France.

Introduction: The case-population approach compares exposure among cases to that of their source population. By using aggregated data to estimate the denominator, this approach can provide a real-time estimate of an association that could be particularly valuable to explore urgent vaccine safety concerns and to generate signals during a vaccine campaign.

Objective: Our objective was to present the vaccine case-population method, a method derived from the case-population approach and adapted for vaccine safety surveillance, and to test it using several published examples.

View Article and Find Full Text PDF

Use of logistic regression to combine two causality criteria for signal detection in vaccine spontaneous report data.

Drug Saf

December 2014

Vaccine Safety Research Group (VSRG), Vaccines Clinical Safety and Pharmacovigilance (VCSP), GlaxoSmithKline Vaccines, Parc de la Noire Epine, Avenue Fleming, 20, 1300, Wavre, Belgium,

Purpose: We evaluated the use of logistic regression to model the probabilities of spontaneously reported vaccine-event pairs being adverse reactions following immunization (ARFI), using disproportionality and unexpectedness of time-to-onset (TTO) distributions as predictive variables and the presence of events in the global product information as a dependent variable.

Methods: We used spontaneous reports of adverse events from eight vaccines and their labels as proxies for ARFIs. Three logistic regressions were built to predict ARFIs based on different combinations of the proportional reporting ratio (PRR; disproportionality measure) and two Kolmogorov-Smirnov (KS) tests ('between vaccines' and the 'between events') of TTO distribution: model 1, using the PRR estimate and its 95% lower confidence interval (CI) limit; model 2, using the p values of the two KS tests; and model 3, using the PRR (point estimate and lower CI limit) and both KS tests.

View Article and Find Full Text PDF

Due to a vaccine-specific reporting bias, it has been recently suggested that some non-live vaccines may be preferentially reported as the suspected cause of the disease or symptoms/signs related to the disease they should prevent. The aim of this study was to analyse the WHO Global Individual Case Safety Report (ICSR) Database, VigiBase, in order to explore this newly described reporting bias in greater detail and to verify whether it can generate potentially misleading signals of disproportionate reporting (SDRs). Vaccines reports entered into VigiBase between 1990 and 2011 were extracted.

View Article and Find Full Text PDF

Vaccines can cause adverse reactions (AR), i.e. adverse events following immunization (AEFIs) due to the vaccine, such as local reactions or fever.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!